HIV Virologic Failure among Patients with Persistent Low‐Level Viremia in Nairobi, Kenya: It Is Time to Review the> 1000 Virologic Failure Threshold

MM Nzivo, CN Waruhiu, JM Kang'ethe… - BioMed Research …, 2023 - Wiley Online Library
Persistent low‐level viremia (PLLV) of 200‐999 copies/ml has been reported as a risk factor
for HIV virologic failure (VF). This retrospective study was aimed at characterizing patients …

Clinical significance and management of low‐level HIV viremia in the era of integrase strand transfer inhibitors

J Shi, G Ying, R Zheng, Z Zhang - HIV medicine, 2024 - Wiley Online Library
Background People living with HIV (PLWH) and receiving antiretroviral therapy (ART) have
a goal of achieving and maintaining viral suppression; however, the existence of PLWH that …

Genotype-Informed versus empiric management of viremia (give move): study protocol of an open-label randomised clinical trial in children and adolescents living …

JA Brown, I Ringera, E Luoga, M Cheleboi… - BMC infectious …, 2020 - Springer
Background Globally, the majority of people living with HIV have no or only limited access to
HIV drug resistance testing to guide the selection of antiretroviral drugs. This is of particular …

Cabotegravir+ Rilpivirine Long-Acting: Overview of Injection Guidance, Injection Site Reactions, and Best Practices for Intramuscular Injection Administration

P Teichner, N Chamay, E Elliot… - Open Forum …, 2024 - academic.oup.com
Background Cabotegravir (CAB)+ rilpivirine (RPV) dosed monthly or every 2 months is a
complete long-acting (LA) regimen for the maintenance of human immunodeficiency virus …

Clinical Relevance of Human Immunodeficiency Virus Low-level Viremia in the Dolutegravir era: Data From the Viral Load Cohort North-East Lesotho (VICONEL)

M Kohler, JA Brown, N Tschumi… - Open Forum …, 2024 - academic.oup.com
Background Human immunodeficiency virus low-level viremia (LLV) is associated with
subsequent treatment failure at least with non nucleoside reverse transcriptase inhibitor …

HIV-1 genotypic resistance testing using sanger and next-generation sequencing in adults with low-level viremia in China

Q Li, F Yu, C Song, H Zhao, Q Xiao, X Lao… - Infection and Drug …, 2022 - Taylor & Francis
Objective In this study, we aimed to determine drug-resistance mutations (DRMs) in HIV-1
patients with low-level viremia (LLV) and explored the performance of next-generation …

Second-line antiretroviral therapy adherence and associated factors among adults living with HIV in Dessie City administration public hospitals, Northeast Ethiopia …

M Mohammed, G Abeje, N Kebede, T Mohammed… - 2023 - researchsquare.com
Background Adherence is a strong predictor of second-line treatment failure. Second-line
treatment failure results in increased morbidity and mortality for HIV-positive patients and is …

[PDF][PDF] Relatório de Recomendação

P Clínico, D Terapêuticas - Ministério da Saúde, 2015 - gov.br
A distonia é caracterizada por contrações musculares involuntárias, sustentadas ou
intermitentes, responsáveis por movimentos e posturas anormais. Trata-se de um distúrbio …

PENERAPAN INTERVENSI INFORMATION MOTIVATION BEHAVIORAL SKILLS PADA PENDERITA HIV UNTUK MENINGKATKAN KEPATUHAN ARV: SCOPING …

A Nurkohilal, S Suhartini, U Sujianto - Jurnal Ilmu Keperawatan dan …, 2023 - ejr.umku.ac.id
Penderita HIV/AIDS memerlukan pengobatan dengan Antiretroviral (ARV) untuk
menurunkan jumlah virus HIV di dalam tubuh. Ketidak patuhan pengobatan dipengaruhi …

Predictors of Virological Failure Among People Living with HIV Switching from an Effective First-Line Antiretroviral Regimen

L Magnasco, R Pincino, G Pasculli… - AIDS Research and …, 2022 - liebertpub.com
Aim of this study was to assess the predictors of virological failure (VF) among patients living
with HIV (PLWHIV) switching from an effective first-line antiretroviral therapy (ART) regimen …